Delta (india) variant increases in UK and US

US

India delta B.1.617.2 variant, in US

May, 8th, 3%

Now, 6%

40 percent more transmissible than the UK alpha variant, B.1.1.7

One vaccine dose, 33 % protection

(50% for alpha variant)

Pfizer-BioNTech and AstraZeneca, 88% effective in preventing symptomatic disease caused by delta

(Moderna probably similar)

70% of adults by 4th July

Now, 63.8%

On track for 67%

Incentives

Burgers, donuts, beers, lottery tickets

Washington State, joints

California, lotteries

West Virginia, trucks and guns

UK

R = 1.3

London, 1.8 on low levels

Portugal now amber

Manchester and Lancashire surge testing and vaccinations

Government, race between jabs and variants is growing "tighter"

25 to 29s from yesterday

Matt Hancock, Indian/Delta variant, 40 per cent more transmissible than Kent/Alpha variant

Increases in recent weeks, concentrated among secondary school-aged children

Matt Hancock formally asked Joint Committee on Vaccination and Immunisation

(JCVI), to produce clinical advice on vaccinating 12- to 17-year-olds

(after the Pfizer jab was approved for this age group)

As of June 3

12,383 cases of Delta variant

464 reported for emergency assessment

126 people admitted to hospital

83 were unvaccinated

28 had received one dose

3 both doses of vaccine

ONS

Prevalence, week ending 29 May 2021

England, 0.16% (1 in 640)

Wales, 0.10% (1 in 1,050)

Northern Ireland, 0.12% (1 in 800)

Scotland, 0.15% (1 in 680)

B.1.617.2 (WHO “Delta”), most common

Infections and deaths

Deaths, week ending 28th May

Most deaths no longer among those aged 75 years and over

England and Wales, total deaths, 3.1% below average

Covid deaths, 95 (down 12 on the week)

Antibody positivity

Week ending 22nd May

England, 80.3% of adults would have tested positive for antibodies

Wales, 82.7%

Northern Ireland, 79.9%

Scotland, 72.6%

Highest among older age groups

Spain

Open to global fully vaccinated

Except, Brazil, India, South Africa,

Official certificates, visitors vaccinated at least 14 days before

Or, Covid-19 infection in the past six months

Vaccines accepted

Those approved by EMA, Pfizer-BioNTech, Moderna, AstraZeneca, Johnson & Johnson

And, World Health Organization approved, Sinopharm and Sinovac

European Union, Digital Green Certificate coming

(Still on UK amber list)